Skip to main content
profile image
Selected Works of Carlo B. Bifulco, M.D.
Article
P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment
Journal of Thoracic Oncology (2017)
  • Rachel Sanborn, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Brian Boulmay, Stanley S. Scott Cancer Center, New Orleans/LA/United States of America
  • Rui Li, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Kyle Happel, Stanley S. Scott Cancer Center, New Orleans/LA/United States of America
  • Sachin Puri, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Christopher Paustian, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Christopher Dubay, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Sandra Aung, Ubivac, Portland/OR/United States of America
  • Brenda Fisher, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Carlo Bifulco, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Keith Bahjat, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Yoshinobu Koguchi, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Augusto Ochoa, Stanley S. Scott Cancer Center, New Orleans/LA/United States of America
  • Hong-Ming Hu, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Traci Hilton, Ubivac, Portland/OR/United States of America
  • Bernard Fox, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
  • Walter Urba, Providence Cancer Center, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Portland/OR/United States of America
Link
Disciplines
Publication Date
January 1, 2017
DOI
10.1016/J.JTHO.2016.11.1190
Citation Information
Rachel Sanborn, Brian Boulmay, Rui Li, Kyle Happel, et al.. "P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment" Journal of Thoracic Oncology Vol. 12 Iss. 1 (2017)
Available at: http://works.bepress.com/carlo-bifulco/78/